The growing popularity of GLP-1 receptor agonists, especially semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), both of which are FDA-approved for type 2 diabetes and/or obesity and, has been accompanied by considerable social media attention and discussion, from which thorough analyses of user-generated data have emerged highlighting reductions in alcohol-seeking motivation, decreased drinking behavior, and altered subjective responses to alcohol (Arillotta et al
Taking Zepbound while breastfeeding is generally not recommended
Dosage Protocols and Administration SLU-PP-332 dosing needs careful consideration based on research objectives
The Northeasts large professional workforce, particularly in finance, law, healthcare, and technology, often has access to generous employer benefits including HSA contributions that can offset medication costs meaningfully
Trulicity (dulaglutide) is an injectable type 2 diabetes medication that helps release insulin when blood glucose rises at mealtime, helps slow down how quickly food leaves the stomach, and can decrease the amount of blood glucose released from the liver
Ensuring adequate protein intake helps maintain muscle mass and supports collagen production, which is essential for skin structure
